等待开盘 10-10 09:30:00 美东时间
-0.022
-2.72%
On September 30, 2025, INVO Fertility, Inc. (the "Company") finalized its settlement agreement with Dr. Elizabeth Pritts ("Dr. Pritts"), consistent with terms of the binding term sheet previously disclosed and filed as
10-04 04:20
(来源:求实药社) 2025年9月23日,恒瑞医药发布公告称,其自主研发的1类创新药SHR7280片的药品上市许可申请获受理。该药物拟定适应症为“在辅助生殖技术...
09-25 11:57
(来源:医疗器械创新网) 01 监管政策与招投标 上海发布高端医疗器械产业全链条发展行动方案 2025 年 9 月 4 日印发,目标 2027 年新增境内三类医...
09-17 07:00
华创证券发布研报称,国内辅助生殖已全面纳入医保,叠加生育补贴等支持政策,行业渗透率有望加速提升。锦欣生殖(01951)作为行业龙头,品牌和牌照优势显著,短期...
09-16 15:20
Femasys Inc. (NASDAQ:FEMY), a leading biomedical innovator making fertility and non-surgical permanent birth control more accessible and cost-effective to women worldwide, announced the introduction of its FemSperm
09-11 21:05
8月31日,长春高新(000661.SZ)在电话会议中表示,目前,子公司金赛药业已拥有重组人促卵泡激素粉剂及水剂产品,预计今年一周注射一次的长效FSH水剂可以获...
09-01 14:27
Cooper Companies (NASDAQ:COO) underwent analysis by 4 analysts in the last quar...
08-28 21:00
中金发布研报称,考虑医保支付和医疗耗材零加成政策影响,下调锦欣生殖(01951)25-26年经调净利润预测59.9%和7.5%至1.70亿元和4.17亿元...
08-28 13:00
人口问题已成为关乎国家未来的重中之重。今年7月,国家层面正式推出育儿补贴政策,这一举措不仅显著激发了母婴消费市场的活力,更重要的是,它正切实帮助许多家庭缓解“想...
08-28 08:52
Cooper Companies (NYSE:COO) is set to give its latest quarterly earnings report...
08-26 23:01